|
1
|
Murphey MD, Robbin MR, McRae GA, Flemming
DJ, Temple HT and Kransdorf MJ: The many faces of osteosarcoma.
Radiographics. 17:1205–1231. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, et al: A meta-analysis of
osteosarcoma outcomes in the modern medical era. Sarcoma.
2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Assi H, Missenard G, Terrier P, Le Pechoux
C, Bonvalot S, Vanel D, et al: Intensive induction chemotherapy
without methotrexate in adult patients with localized osteosarcoma:
results of the Institut Gustave-Roussy phase II trial. Curr Oncol.
17:23–31. 2010. View Article : Google Scholar
|
|
5
|
Balkwill F and Mantovani A: Inflammation
and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
8
|
Cole SW: Chronic inflammation and breast
cancer recurrence. Journal Clinical Oncology. 27:3418–3419. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Crawford S: Anti-inflammatory/antioxidant
use in long-term maintenance cancer therapy: A new therapeutic
approach to disease progression and recurrence. Ther Adv Med Oncol.
6:52–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Noh K, Kim KO, Patel NR, Staples JR,
Minematsu H, Nair K, et al: Targeting inflammatory kinase as an
adjuvant treatment for osteosarcomas. J Bone Joint Surg Am.
93:723–732. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu C, Pan C, Shen J, Wang H and Yong L:
Identification of serum amyloid A in the serum of gastric cancer
patients by protein expression profiling. Oncol Lett. 3:1259–1262.
2012.PubMed/NCBI
|
|
12
|
Mittal A, Poudel B, Pandeya DR, Gupta SP,
Sathian B and Yadav K: Serum amyloid a as an independent prognostic
factor for renal cell carcinoma - a hospital based study from the
Western region of Nepal. Asian Pac J Cancer Prev. 13:2253–2255.
2012. View Article : Google Scholar
|
|
13
|
Zhang G, Sun X, Lv H, Yang X and Kang X:
Serum amyloid A: A new potential serum marker correlated with the
stage of breast cancer. Oncol Lett. 3:940–944. 2012.PubMed/NCBI
|
|
14
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Desai B, Rogers MJ and Chellaiah MA:
Mechanisms of osteopontin and CD44 as metastatic principles in
prostate cancer cells. Mol Cancer. 6:182007. View Article : Google Scholar
|
|
16
|
Sung V, Stubbs JT 3rd, Fisher L, Aaron AD
and Thompson EW: Bone sialoprotein supports breast cancer cell
adhesion proliferation and migration through differential usage of
the alpha(v)beta3 and alpha(v)beta5 integrins. J Cell Physiol.
176:482–494. 1998. View Article : Google Scholar
|
|
17
|
Pecheur I, Peyruchaud O, Serre CM,
Guglielmi J, Voland C, Bourre F, et al: Integrin alpha(v)beta3
expression confers on tumor cells a greater propensity to
metastasize to bone. FASEB J. 16:1266–1268. 2002.PubMed/NCBI
|
|
18
|
Tome Y, Kimura H, Maehara H, Sugimoto N,
Bouvet M, Tsuchiya H, et al: High lung-metastatic variant of human
osteosarcoma cells, selected by passage of lung metastasis in nude
mice, is associated with increased expression of alphavbeta3
integrin. Anticancer Res. 33:3623–3627. 2013.
|
|
19
|
Kurihara Y, Nakahara T and Furue M:
alphaVbeta3-integrin expression through ERK activation mediates
cell attachment and is necessary for production of tumor necrosis
factor alpha in monocytic THP-1 cells stimulated by phorbol
myristate acetate. Cell Immunol. 270:25–31. 2011. View Article : Google Scholar
|
|
20
|
Furundzija V, Fritzsche J, Kaufmann J,
Meyborg H, Fleck E, Kappert K, et al: IGF-1 increases macrophage
motility via PKC/p38-dependent alphavbeta3-integrin inside-out
signaling. Biochem Biophys Res Commun. 394:786–791. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li B, Dong Z, Liu H, Xia YF, Liu XM, Luo
BB, et al: Serum amyloid A stimulates lipoprotein-associated
phospholipase A2 expression in vitro and in vivo. Atherosclerosis.
228:370–379. 2013. View Article : Google Scholar
|
|
22
|
Dong Z, An F, Wu T, Zhang C, Zhang M,
Zhang Y, et al: PTX3, a key component of innate immunity, is
induced by SAA via FPRL1-mediated signaling in HAECs. J Cell
Biochem. 112:2097–2105. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levinson H, Hopper JE and Ehrlich HP:
Overexpression of integrin alphav promotes human osteosarcoma cell
populated collagen lattice contraction and cell migration. J Cell
Physiol. 193:219–224. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Uhlar CM and Whitehead AS: Serum amyloid
A, the major vertebrate acute-phase reactant. Eur J Biochem.
265:501–523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tölle M, Huang T, Schuchardt M, Jankowski
V, Prufer N, Jankowski J, et al: High-density lipoprotein loses its
anti-inflammatory capacity by accumulation of
pro-inflammatory-serum amyloid A. Cardiovasc Res. 94:154–162.
2012.PubMed/NCBI
|
|
26
|
d’Eril GM, Anesi A, Maggiore M and Leoni
V: Biological variation of serum amyloid A in healthy subjects.
Clin Chem. 47:1498–1499. 2001.PubMed/NCBI
|
|
27
|
Shattil SJ, Kim C and Ginsberg MH: The
final steps of integrin activation: the end game. Nat Rev Mol Cell
Biol. 11:288–300. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Duan X, Jia SF, Zhou Z, Langley RR,
Bolontrade MF and Kleinerman ES: Association of alphavbeta3
integrin expression with the metastatic potential and migratory and
chemotactic ability of human osteosarcoma cells. Clin Exp
Metastasis. 21:747–753. 2004. View Article : Google Scholar
|
|
29
|
Song C, Hsu K, Yamen E, Yan W, Fock J,
Witting PK, et al: Serum amyloid A induction of cytokines in
monocytes/macrophages and lymphocytes. Atherosclerosis.
207:374–383. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pechkovsky DV, Scaffidi AK, Hackett TL,
Ballard J, Shaheen F, Thompson PJ, et al: Transforming growth
factor beta1 induces alphavbeta3 integrin expression in human lung
fibroblasts via a beta3 integrin-, c-Src-, and p38 MAPK-dependent
pathway. J Biol Chem. 283:12898–12908. 2008. View Article : Google Scholar : PubMed/NCBI
|
